63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

47 trials found

diseases per page:

Showing 1 to 10 of 47 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2071210087	04/02/2022	29/10/2021	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	Primary Immune Thrombocytopenia	Patients will receive ARGX-113 PH20 SC (1000 mg of EfgartigimodAlfa) weekly or biweekly ( continue a ...	Gandini Domenica	NULL	Recruiting	>= 20age old	Not applicable	Both	9	Phase 3	Argentina;Australia;Bulgaria;Chile;China;Colombia;Denmark;France;Georgia;Germany;Greece;Ireland;Isra ...
2	EUCTR2020-004032-21-DK (EUCTR)	11/01/2022	16/04/2021	A Phase 3 study to evaluate the efficacy and safety of efgartigimodPH 20 Subcutaneous in adult patie ...	A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficac ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
3	NCT04812925 (ClinicalTrials.gov)	November 17, 2021	15/3/2021	A Phase 3 Study to Evaluate the Safety and Efficacy of EfgartigimodPH20 Subcutaneous in Adult Patien ...	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	Primary Immune Thrombocytopenia	Biological: efgartigimod PH20 SC	argenx	NULL	Recruiting	18 Years	N/A	All	156	Phase 3	United States;Argentina;Australia;Bulgaria;Chile;China;Georgia;Greece;Ireland;Italy;Japan;Jordan;Kor ...
4	EUCTR2020-004033-20-RO (EUCTR)	06/10/2021	20/04/2022	Study to Evaluate the Safety and Efficacy of Efgartigimod(ARGX-113) PH20 Subcutaneous in Adult Patie ...	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
5	EUCTR2020-004033-20-NO (EUCTR)	08/09/2021	20/04/2021	Study to Evaluate the Safety and Efficacy of Efgartigimod(ARGX-113) PH20 Subcutaneous in Adult Patie ...	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
6	EUCTR2020-004033-20-GR (EUCTR)	07/09/2021	19/07/2021	Study to Evaluate the Safety and Efficacy of Efgartigimod(ARGX-113) PH20 Subcutaneous in Adult Patie ...	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
7	EUCTR2020-004033-20-BG (EUCTR)	03/09/2021	26/05/2021	Study to Evaluate the Safety and Efficacy of Efgartigimod(ARGX-113) PH20 Subcutaneous in Adult Patie ...	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
8	EUCTR2020-004033-20-PT (EUCTR)	03/09/2021	20/05/2021	Study to Evaluate the Safety and Efficacy of Efgartigimod(ARGX-113) PH20 Subcutaneous in Adult Patie ...	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
9	EUCTR2020-004033-20-ES (EUCTR)	13/08/2021	09/06/2021	Study to Evaluate the Safety and Efficacy of Efgartigimod(ARGX-113) PH20 Subcutaneous in Adult Patie ...	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC INN or Proposed INN: efgartigimod alfa	argenx BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...
10	EUCTR2020-004033-20-IT (EUCTR)	23/07/2021	17/08/2021	Study to Evaluate the Safety and Efficacy of Efgartigimod(ARGX-113) PH20 Subcutaneous in Adult Patie ...	A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigi ...	Primary immune thrombocytopenia (ITP) MedDRA version: 23.0;Level: LLT;Classification code 10083843;T ...	Product Name: efgartigimod PH20 SC Product Code: [ARGX-113] INN or Proposed INN: efgartigimod alfa	ARGENX BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	156	Phase 3	Portugal;Serbia;United States;Taiwan;Greece;Spain;Thailand;Ireland;Israel;Chile;Russian Federation;C ...

First Previous1 2 3 4 5Next Last